Holen Sie sich die Stockscreener-App
18.94
2.99%
0.55
Handel nachbörslich:
18.94
Finanzdaten der Apellis Pharmaceuticals Inc-Aktie (APLS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
156.92%
458.58
|
178.49 | 166.80 | 212.53 | 196.83 |
Operating Expenses
|
11.15%
235.40
|
211.78 | 250.12 | 238.69 | 244.11 |
| Benefits Costs and Expenses |
10.03%
242.26
|
220.18 | 258.68 | 248.59 | 253.68 |
| Costs And Expenses |
10.03%
242.26
|
220.18 | 258.68 | 248.59 | 253.68 |
| Operating Income/Loss |
770.50%
223.18
|
-33.29 | -83.33 | -26.16 | -47.28 |
| Income/Loss From Continuing Operations Before Tax |
618.93%
216.32
|
-41.69 | -91.88 | -36.07 | -56.85 |
| Income Tax Expense/Benefit |
29.18%
0.602
|
0.466 | 0.341 | 0.286 | 0.592 |
| Income/Loss From Continuing Operations After Tax |
611.77%
215.72
|
-42.15 | -92.22 | -36.35 | -57.45 |
|
Net Income/Loss
|
611.77%
215.72
|
-42.15 | -92.22 | -36.35 | -57.45 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.32%
126.42
|
126.02 | 125.45 | 0.207 | 124.23 |
| Diluted Average Shares |
3.21%
130.07
|
126.02 | 125.45 | 0.207 | 124.23 |
| Basic Earnings Per Share |
618.18%
1.71
|
-0.33 | -0.74 | -0.29 | -0.46 |
| Diluted Earnings Per Share |
606.06%
1.67
|
-0.33 | -0.74 | -0.29 | -0.46 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):